Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss

被引:27
|
作者
Zhang, Xuelian [1 ,2 ,3 ,4 ]
Zhang, Bin [1 ,2 ,3 ,4 ]
Zhang, Chenyang [1 ,2 ,3 ,4 ]
Sun, Guibo [1 ,2 ,3 ,4 ]
Sun, Xiaobo [1 ,2 ,3 ,4 ]
机构
[1] Peking Union Med Coll & Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China
[2] Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ, Beijing, Peoples R China
[3] Beijing Key Lab Innovat Drug Discovery Tradit Chi, Beijing, Peoples R China
[4] State Adm Tradit Chinese Med, Key Lab Efficacy Evaluat Chinese Med Glyeolipid M, Beijing, Peoples R China
关键词
anti-obesity; adipogenesis; lipolysis; browning of white adipose tissue; insulin sensitivity; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; WHITE ADIPOSE-TISSUE; DIET-INDUCED OBESITY; GINSENOSIDE RB1; PPAR-GAMMA; INSULIN-RESISTANCE; BROWN FAT; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION;
D O I
10.3389/fphar.2020.601751
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The prevalence of individuals who are overweight or obese is rising rapidly globally. Currently, majority of drugs used to treat obesity are ineffective or are accompanied by obvious side effects; hence, the options are very limited. Therefore, it is necessary to find more effective and safer anti-obesity drugs. It has been proven in vivo and in vitro that the active ingredient notoginsenosides isolated from traditional Chinese medicine Panax notoginseng (Burk.) F. H. Chen exhibits anti-obesity effects. Notoginsenosides can treat obesity by reducing lipid synthesis, inhibiting adipogenesis, promoting white adipose tissue browning, increasing energy consumption, and improving insulin sensitivity. Although notoginsenosides are potential drugs for the treatment of obesity, their effects and mechanisms have not been analyzed in depth. In this review, the anti-obesity potential and mechanism of action of notoginsenosides were analyzed; thus laying emphasis on the timely prevention and treatment of obesity.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
    Guglielmi, Valeria
    Bettini, Silvia
    Sbraccia, Paolo
    Busetto, Luca
    Pellegrini, Massimo
    Yumuk, Volkan
    Colao, Anna Maria
    El Ghoch, Marwan
    Muscogiuri, Giovanna
    CURRENT OBESITY REPORTS, 2023, 12 (02) : 127 - 146
  • [42] The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
    Ghusn, Wissam
    Fansa, Sima
    Anazco, Diego
    Tama, Elif
    Cifuentes, Lizeth
    Gala, Khushboo
    de la Rosa, Alan
    Sacoto, Daniel
    Campos, Alejandro
    Feris, Fauzi
    Hurtado, Daniela
    Acosta, Andres
    DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2167 - 2175
  • [43] No 'easy' weight loss: don't overlook the social cost of anti-obesity drugs
    Brewis, Alexandra
    Trainer, Sarah
    NATURE, 2024, 626 (7998) : 258 - 260
  • [44] TIMING OF ANTI-OBESITY MEDICATIONS FOR THE TREATMENT OF WEIGHT LOSS PLATEAU FOLLOWING METABOLIC SURGERY
    Kim, S.
    Lee, S.
    Park, J.
    Shin, J.
    Kim, K.
    Ihn, M.
    OBESITY SURGERY, 2022, 32 (SUPPL 2) : 572 - 573
  • [45] Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
    Valeria Guglielmi
    Silvia Bettini
    Paolo Sbraccia
    Luca Busetto
    Massimo Pellegrini
    Volkan Yumuk
    Anna Maria Colao
    Marwan El Ghoch
    Giovanna Muscogiuri
    Current Obesity Reports, 2023, 12 : 127 - 146
  • [46] Alternative Treatments for Weight Loss: Safety/Risks and Effectiveness of Anti-Obesity Medicinal Plants
    Kazemipoor, Mahnaz
    Cordell, Geoffrey A.
    Sarker, Md Moklesur Rahman
    Radzi, Che Wan Jasimah Bt Wan Mohamed
    Hajifaraji, Majid
    Kiat, Phua En
    INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2015, 18 (09) : 1942 - 1963
  • [47] Alternative Treatments for Weight Loss: Safety/Risks and Effectiveness of Anti-Obesity Medicinal Plants
    Department of Science and Technology Studies, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
    不详
    IL, United States
    不详
    FL, United States
    不详
    不详
    Int. J. Food Prop., 9 (1942-1963):
  • [48] No ‘easy’ weight loss: don’t overlook the social cost of anti-obesity drugs
    Alexandra Brewis
    Sarah Trainer
    Nature, 2024, 626 : 258 - 260
  • [49] Physiological genomic approach to assess the anti-obesity potential of a novel weight loss supplement
    Bagchi, Debasis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [50] Gastric Cytokines, Gastric Microbial Overgrowth and Weight Loss After Anti-Obesity Gastroplasty
    Faintuch, Joel
    Ishida, Robson K.
    Kuga, Rogerio
    Ribeiro, Adriana S.
    Sakai, Paulo
    Ishioka, Shinichi
    Barbeiro, Hermes V.
    Barbeiro, Denise F.
    Soriano, Francisco G.
    Mattar, Rejane
    Mijakabi, Miyoko
    Zilberstein, Bruno
    Cecconello, Ivan
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB172 - AB172